9 Suppression of IDH1 has no effect on S-phase and neither propionylcarnitine nor butyrylcarnitine rescue DNA damage
[DOI] [PubMed] [Google Scholar] 91.Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C
Patients with a history of gallbladder disease can still be considered for semaglutide therapy but may require closer monitoring for symptoms of gallbladder issues
However, research is still ongoing, and more large-scale clinical studies are needed to fully confirm these effects
Clinical studies in normal subjects showed GH secretion of 1434.8 plus or minus 393.0 after GHRP-6 administration alone, compared to 483.7 plus or minus 99.2 after GHRH alone
[DOI] [PMC free article] [PubMed] [Google Scholar] Omodanisi EI, Aboua YG, Oguntibeju OO